Literature DB >> 29062752

Technical pitfalls and tips for the valve-in-valve procedure.

Vinayak Bapat1.   

Abstract

Transcatheter aortic valve implantation (TAVI) has emerged as a viable treatment modality for patients with severe aortic valve stenosis and multiple co-morbidities. More recent indications include the use of transcatheter heart valves (THV) to treat degenerated bioprosthetic surgical heart valves (SHV), which are failing due to stenosis or regurgitation. Valve-in-valve (VIV) procedures in the aortic position have been performed with a variety of THV devices, although the balloon-expandable SAPIEN valve platform (Edwards Lifesciences Ltd, Irvine, CA, USA) and self-expandable CoreValve platform (Medtronic Inc., MN, USA) have been used in majority of the patients. VIV treatment is appealing as it is less invasive than conventional surgery but optimal patient selection is vital to avoid complications such as malposition, residual high gradients and coronary obstruction. To minimize the risk of complications, thorough procedural planning is critical. The first step is identification of the degenerated SHV, including its model, size, fluoroscopic appearance. Although label size and stent internal diameter (ID) are provided by the manufacturer, it is important to note the true ID. The true ID is the ID of a SHV after the leaflets are mounted and helps determine the optimal size of THV. The second step is to determine the type and size of the THV. Although this is determined in the majority of the cases by user preference, in certain situations one THV may be more suitable than another. As the procedure is performed under fluoroscopy, the third step is to become familiarized with the fluoroscopic appearance of both the SHV and THV. This helps to determine the landmarks for optimal positioning, which in turn determines the gradients and fixation. The fourth step is to assess the risk of coronary obstruction. This is performed with either aortic root angiography or ECG-gated computerised tomography (CT). Finally, the route of approach must be carefully planned. Once these aspects are addressed, the procedure can be performed efficiently with a low risk of complications.

Entities:  

Keywords:  Valve; bioprosthesis; transcatheter aortic valve implantation (TAVI); transcatheter valve; valve-in-valve (VIV)

Year:  2017        PMID: 29062752      PMCID: PMC5639225          DOI: 10.21037/acs.2017.09.13

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN: 2225-319X


  18 in total

1.  Transcatheter aortic valve implantation for the treatment of surgical valve dysfunction ("valve-in-valve"): assessing the risk of coronary obstruction.

Authors:  Marina Urena; Luis Nombela-Franco; Daniel Doyle; Robert De Larochellière; Eric Dumont; Jacques Villeneuve; Sergio M Pasian; Michel Gingras; Michael Mok; Josep Rodés-Cabau
Journal:  J Card Surg       Date:  2012-09-27       Impact factor: 1.620

Review 2.  Computed tomography assessment for transcatheter aortic valve in valve implantation: The vancouver approach to predict anatomical risk for coronary obstruction and other considerations.

Authors:  Philipp Blanke; Jeanette Soon; Danny Dvir; Jong K Park; Christopher Naoum; Shaw-Hua Kueh; David A Wood; Bjarne L Norgaard; Kapilan Selvakumar; Jian Ye; Anson Cheung; John G Webb; Jonathon Leipsic
Journal:  J Cardiovasc Comput Tomogr       Date:  2016-09-24

3.  Aortic biological valve prosthesis in patients younger than 65 years of age: transition to a flexible age limit?

Authors:  Lars Niclauss; Ludwig Karl von Segesser; Enrico Ferrari
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-03

Review 4.  Transcatheter heart valve implantation for failing surgical bioprostheses: technical considerations and evidence for valve-in-valve procedures.

Authors:  Dagrren Mylotte; Ruediger Lange; Giuseppe Martucci; Nicolo Piazza
Journal:  Heart       Date:  2013-02-13       Impact factor: 5.994

5.  Neo-annulus: a reference plane in a surgical heart valve to facilitate a valve-in-valve procedure.

Authors:  Vinayak Bapat; Benjamin Adams; Rizwan Attia; Alia Noorani; Martyn Thomas
Journal:  Catheter Cardiovasc Interv       Date:  2014-07-25       Impact factor: 2.692

6.  Effect of valve design on the stent internal diameter of a bioprosthetic valve: a concept of true internal diameter and its implications for the valve-in-valve procedure.

Authors:  Vinayak N Bapat; Rizwan Attia; Martyn Thomas
Journal:  JACC Cardiovasc Interv       Date:  2014-01-15       Impact factor: 11.195

7.  Valve-in-valve apps: why and how they were developed and how to use them.

Authors:  Vinayak Bapat
Journal:  EuroIntervention       Date:  2014-09       Impact factor: 6.534

8.  Blood Stasis on Transcatheter Valve Leaflets and Implications for Valve-in-Valve Leaflet Thrombosis.

Authors:  Koohyar Vahidkhah; Shahnaz Javani; Mostafa Abbasi; Peyman N Azadani; Anwar Tandar; Danny Dvir; Ali N Azadani
Journal:  Ann Thorac Surg       Date:  2017-05-05       Impact factor: 4.330

9.  Percutaneous transvenous Melody valve-in-ring procedure for mitral valve replacement.

Authors:  Takashi Shuto; Norihiro Kondo; Yoav Dori; Kevin J Koomalsingh; Andrew C Glatz; Jonathan J Rome; Joseph H Gorman; Robert C Gorman; Matthew J Gillespie
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

10.  Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and results.

Authors:  Vinayak Bapat; William Davies; Rizwan Attia; Jane Hancock; Kirsty Bolter; Christopher Young; Simon Redwood; Martyn Thomas
Journal:  J Thorac Cardiovasc Surg       Date:  2014-05-16       Impact factor: 5.209

View more
  3 in total

1.  Direct access valve-in-valve implantation for management of complex valvulopathy.

Authors:  Alexander P Kossar; Michael Borger; Isaac George
Journal:  Catheter Cardiovasc Interv       Date:  2019-04-08       Impact factor: 2.692

2.  Transcatheter Double Valve-in-Valve Replacement of Aortic and Mitral Bioprosthetic Valves.

Authors:  Javad Savoj; Syed Iftikhar; Steven Burstein; Patrick Hu
Journal:  Cardiol Res       Date:  2019-06-07

3.  Distance between valvular leaflet and coronary ostium predicting risk of coronary obstruction during TAVR.

Authors:  Jun-Hyok Oh; Yuhei Kobayashi; Guson Kang; Takeshi Nishi; Martin J Willemink; William F Fearon; Michael Fischbein; Dominik Fleishmann; Alan C Yeung; Juyong Brian Kim
Journal:  Int J Cardiol Heart Vasc       Date:  2021-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.